المؤلفون: Shifu Xiao, Piu Chan, Tao Wang, Zhen Hong, Shuzhen Wang, Weihong Kuang, Jincai He, Xiaoping Pan, Yuying Zhou, Yong Ji, Luning Wang, Yan Cheng, Ying Peng, Qinyong Ye, Xiaoping Wang, Yuncheng Wu, Qiumin Qu, Shengdi Chen, Shuhua Li, Wei Chen, Jun Xu, Dantao Peng, Zhongxin Zhao, Yansheng Li, Junjian Zhang, Yifeng Du, Weixian Chen, Dongsheng Fan, Yong Yan, Xiaowei Liu, Wei Zhang, Benyan Luo, Wenyuan Wu, Lu Shen, Chunfeng Liu, Peixian Mao, Qiumei Wang, Qianhua Zhao, Qihao Guo, Yongtao Zhou, Yi Li, Lijun Jiang, Wenwei Ren, Yingjun Ouyang, Yan Wang, Shuai Liu, Jianjun Jia, Nan Zhang, Zhonglin Liu, Raoli He, Tingyi Feng, Wenhui Lu, Huidong Tang, Ping Gao, Yingchun Zhang, Lanlan Chen, Lei Wang, You Yin, Qun Xu, Jinsong Xiao, Lin Cong, Xi Cheng, Hui Zhang, Dan Gao, Minghua Xia, Tenghong Lian, Guoping Peng, Xu Zhang, Bin Jiao, Hua Hu, Xueyan Chen, Yihui Guan, Ruixue Cui, Qiu Huang, Xianliang Xin, Hongjian Chen, Yu Ding, Jing Zhang, Teng Feng, Marc Cantillon, Kewei Chen, Jeffrey L. Cummings, Jian Ding, Meiyu Geng, Zhenxin Zhang

المصدر: Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Sodium oligomannate, Efficacy, Safety, Alzheimer’s disease, Clinical trial, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-9193

URL الوصول: https://doaj.org/article/be6ea2cb11804b00bae73772fe2c6adc

المؤلفون: Xianliang Xin, Huidong Tang, Meiyu Geng, Dongsheng Fan, Yi Li, Qinyong Ye, Shuai Liu, Lu Shen, Wenwei Ren, Zhenxin Zhang, Dan Gao, Jian Ding, You Yin, Junjian Zhang, Raoli He, Dantao Peng, Qiumei Wang, Xueyan Chen, Lanlan Chen, Yong Yan, Xu Zhang, Yingchun Zhang, Zhen Hong, Yu Ding, Wei Chen, Jinsong Xiao, Marc Cantillon, Yan Wang, Bin Jiao, Xiaowei Liu, Hui Zhang, Benyan Luo, Ying Peng, Hua Hu, Lijun Jiang, Jincai He, Teng Feng, Yongtao Zhou, Chun-Feng Liu, Yuying Zhou, Jianjun Jia, Yihui Guan, Qiu Huang, Yong Ji, Tingyi Feng, Shuhua Li, Yifeng Du, Nan Zhang, Yuncheng Wu, Jeffrey L. Cummings, Lin Cong, Xiaoping Pan, Wenyuan Wu, Xi Cheng, Minghua Xia, Hongjian Chen, Weihong Kuang, Qiumin Qu, Guoping Peng, Shuzhen Wang, Luning Wang, Shifu Xiao, Wenhui Lu, Kewei Chen, Peixian Mao, Lei Wang, Zhongxin Zhao, Qihao Guo, Xiaoping Wang, Shengdi Chen, Zhonglin Liu, Qianhua Zhao, Qun Xu, Piu Chan, Tao Wang, Ping Gao, Jing Zhang, Yansheng Li, Yan Cheng, Ruixue Cui, Jun Xu, Weixian Chen, Yingjun Ouyang, Wei Zhang, Tenghong Lian

المصدر: Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: medicine.medical_specialty, China, Neurology, Efficacy, Cognitive Neuroscience, Phases of clinical research, Oligosaccharides, Placebo, lcsh:RC346-429, lcsh:RC321-571, Double-Blind Method, Alzheimer Disease, Internal medicine, Activities of Daily Living, medicine, Humans, Adverse effect, lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry, lcsh:Neurology. Diseases of the nervous system, business.industry, Incidence (epidemiology), Research, Sodium, Sodium oligomannate, Confidence interval, Clinical trial, Treatment Outcome, Tolerability, Pharmaceutical Preparations, Neurology (clinical), Cholinesterase Inhibitors, Safety, business, Alzheimer’s disease, Mannose

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4dfc2bb564b087c3d6c373f24f3ad1c
http://europepmc.org/articles/PMC7967962